These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 16433896

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
    Inaba T, Fischer NE, Riddick DS, Stewart DJ, Hidaka T.
    Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.
    Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2001 Feb; 29(2):100-2. PubMed ID: 11159797
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR.
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
    Iribarne C, Berthou F, Carlhant D, Dreano Y, Picart D, Lohezic F, Riche C.
    Drug Metab Dispos; 1998 Mar; 26(3):257-60. PubMed ID: 9492389
    [Abstract] [Full Text] [Related]

  • 14. In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors.
    Zalma A, von Moltke LL, Granda BW, Harmatz JS, Shader RI, Greenblatt DJ.
    Biol Psychiatry; 2000 Apr 01; 47(7):655-61. PubMed ID: 10745059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
    Gupta A, Zhang Y, Unadkat JD, Mao Q.
    J Pharmacol Exp Ther; 2004 Jul 01; 310(1):334-41. PubMed ID: 15007102
    [Abstract] [Full Text] [Related]

  • 19. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
    van Heeswijk RP, Veldkamp A, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM.
    Antivir Ther; 2001 Dec 01; 6(4):201-29. PubMed ID: 11878403
    [Abstract] [Full Text] [Related]

  • 20. Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir.
    von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Duan SX, Fogelman SM, Daily JP, Harmatz JS, Shader RI.
    J Clin Pharmacol; 1998 Feb 01; 38(2):106-11. PubMed ID: 9549640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.